Hugo W. Moser Research Institute at Kennedy Krieger
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hugo W. Moser Research Institute at Kennedy Krieger sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Hugo W. Moser Research Institute at Kennedy Krieger: 73 sponsored US clinical trials, 17 recruiting.
Hugo W. Moser Research Institute at Kennedy Krieger sponsors 73 registered US clinical trials on ClinicalTrials.gov, 17 of them currently recruiting, and 40 completed. 4 of these trials are in Phase 3-4 (later-stage) and 13 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 5 trials.
Top-decile sponsor footprint
Hugo W. Moser Research Institute at Kennedy Krieger ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
40 of 48 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 2 of 2
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
NCT01694667
Long Term Split Belt Treadmill Training for Stroke Recovery
NCT01646216
Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy
NCT01594853
National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database
NCT01591694
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
NCT01632293
Placebo Controlled Trial of Dextromethorphan in Rett Syndrome
NCT01520363
Social Cognitive Development in Young Children With Autism
NCT01425918
School-Age Children With Autism With Limited Expressive Language Skills
NCT01529580
Virtual Sailing Simulator in Individuals With Spinal Cord Injury
NCT01491789
Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury
NCT01479777
Exercise Training Program for Cerebellar Ataxia
NCT01307176
Locomotor Training for Neurological Disease
NCT01288040
Study on Functional Electrical Stimulation (FES) Cycling Following Spinal Cord Injury
NCT01217047
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
NCT01168908
Biomarker Development in Sturge-Weber Syndrome
NCT01345305
A Randomized Clinical Trial for Toddlers With ASD
NCT01008800
Patterned Functional Electrical Stimulation (FES) Ergometry of Arm and Shoulder in Individuals With Spinal Cord Injury
NCT01005615
Yulex Glove Prospective Study in Spina Bifida
NCT01133288
Yoga Based Psychotherapy Group Feasibility and Efficacy Study
NCT01524172
Intervention for Toddlers at Risk for Autism Spectrum Disorders (ASD)
NCT01179841
Trial of Dextromethorphan in Rett Syndrome
NCT00593957
School- and Home-Based Early Intervention for Toddlers With Autism
NCT00106210
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
NCT00004418
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Phase 4 | 3 |
What is open in the Hugo W. Moser Research Institute at Kennedy Krieger pipeline
17 recruiting of 73 indexed (23% open); 40 completed (55%).
Phase mix: 4 late (III/IV) vs 13 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hugo W. Moser Research Institute at Kennedy Krieger: open-pipeline peers nationwide
Peers matched on 73 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Hugo W. Moser Research Institute at Kennedy Krieger sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Joslin Diabetes Center · 73 trials · 10% recruiting
- Massachusetts Eye and Ear Infirmary · 73 trials · 27% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Major Extremity Trauma Research Consortium · 23% recruiting · 30 trials
- Scripps Health · 23% recruiting · 30 trials
- Texas A&M University · 23% recruiting · 95 trials
- Clemson University · 23% recruiting · 13 trials
Related
What to do with this Hugo W. Moser Research Institute at Kennedy Krieger page
73 registered trials is a research-attention snapshot, not an endorsement of Hugo W. Moser Research Institute at Kennedy Krieger or any single study.
- 17 of Hugo W. Moser Research Institute at Kennedy Krieger's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Hugo W. Moser Research Institute at Kennedy Krieger studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hugo W. Moser Research Institute at Kennedy Krieger pipeline card: 73 registered trials from official public datasets.Report a data error.